New assay enables hospitals to provide efficiency improvements in cardiac patient management BREA, CALIF. — (Nov 7, 2017) — Beckman Coulter Diagnostics announced today that it has received CE Mark clearance for a new high-sensitivity troponin (hsTnI) assay that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms. “The new,... Read more
Project to improve biomedical data efficiency and reliability NEW YORK, November 7, 2017 /PRNewswire/ — Elsevier and Seven Bridges Genomics announced today that The National Institutes of Health (NIH) has awarded them a grant for the development of a comprehensive, open-source data analysis ecosystem as part of its Data Commons Pilot Phase. The project is designed to improve data efficiency and reliability for... Read more
November 6, 2017 Consortium will build cloud-based data resources, tools, and interoperable standards, giving researchers simultaneous access to biomedical datasets from across the National Institutes of Health CAMBRIDGE, Mass., November 06, 2017 – Seven Bridges, the leading biomedical data analysis company, today announced that it has been selected by the National Institutes of Health (NIH) to support... Read more
Download PDF Read more
31. July 2018 – 03. August 2018 Visit Greiner Bio-One at booth 1440 at the AACC! JOIN THE GLOBAL LABORATORY MEDICINE COMMUNITY The 70th AACC Annual Scientific Meeting & Clinical Lab Expo is the largest global scientific conference and tradeshow in the field of laboratory medicine. At this dynamic meeting, you’ll have the opportunity to:... Read more
Key Discoveries in the Therapeutic Application of Cord Blood: Improvement of Motor Function in Children with Cerebral Palsy WALTHAM, Mass.–(BUSINESS WIRE)– Research published in Stem Cells Translational Medicine shows encouraging developments related to using a child’s own cord blood to treat childhood brain injury known as cerebral palsy (CP). The research from a Phase II... Read more
Thermo Fisher Scientific Signs Oncology Companion Diagnostic Development Agreement with Blueprint Medicines Agreement to expand Oncomine Dx Target Test with RET fusion markers to treat non-small cell lung cancer patients CARLSBAD, Calif., Oct. 31, 2017 /PRNewswire/ — As part of its ongoing commitment to increase the utility of next-generation sequencing (NGS) in the clinic, Thermo Fisher... Read more
Basel, 31 October 2017 New data suggest Roche’s etrolizumab can provide clinically meaningful improvements in the treatment of two of the most common forms of inflammatory bowel disease Roche presents etrolizumab data in Crohn’s disease and ulcerative colitis at UEGW Data suggest etrolizumab leads to endoscopic improvement associated with early symptomatic remission in Crohn’s disease... Read more
Trusted QIAGEN partners can now increase their speed to market by leveraging the company’s industry expertise, world-class manufacturing and thousands of product formulations Beverly, Mass., October 30, 2017 – QIAGEN today announced the launch of its Custom Solutions business, extending its commitment to providing life sciences and molecular diagnostics companies with the tools and expertise... Read more